ScaleReady’s Post

Thoughts on this? >> World's Most Expensive Drug Is Now $4.25 Million Gene Therapy - Bloomberg >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #competitivemarketing #healthcare

Halfway through 2024, three key trends are shaping pharma companies: - Biopharmaceutical companies are experiencing an innovation renaissance. - The cell and gene therapy (CGT) market is expanding with innovative approaches. - Momentum is growing to address gaps and disparities in women’s health. To delve deeper into how these trends are influencing the industry, check out the full Deloitte report: [Link to the report](https://lnkd.in/exYV8jph)

Thoughts on this? >> World's Most Expensive Drug Is Now $4.25 Million Gene Therapy - Bloomberg >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech

Thoughts on this? >> FDA's Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #pharma #productmarketing

Supply chain disruptions continue to plague the biopharma industry, but collaboration is key to building a more stable future. The year ahead is likely to bring advancements in manufacturing technology and automation that ill significantly impact cell and gene therapy production. How can we strengthen collaboration across the biopharma ecosystem to ensure a steady supply of critical medicines?     Discover more: https://lnkd.in/g2AgsfdD    #biopharma #supplychain #collaboration #resilience

How To Leverage Platform And Process Characterization Data To Accelerate Cell & Gene Therapies https://lnkd.in/e6_tMDVR Points to consider on how companies can use prior knowledge and platforms to leverage process characterization to reduce the testing and/or studies required during process validation for drug substance (DS) and drug product (DP) manufacturing processes.

Thoughts on this? >> Beacon raises $170M to take on J&J in ocular gene therapy >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #productmarketing #biotech

Thoughts on this? >> CompareNetworks to Launch Cell & Gene Therapy Review, the Industry's Newest Authority on Cell and Gene Therapy Business and Technology - PR Web >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #competitivemarketing #biotech #pharmaceutical

Thoughts on this? >> Exclusive: Backed by MIT’s Andrew Lo, Quantile Health raises $6M to bolster gene therapy access >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #productmarketing

Thoughts on this? >> #ASRS24: Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #healthcare #pharma #biotech